<DOC>
	<DOC>NCT01466049</DOC>
	<brief_summary>The purpose of this study is to evaluate new biomarkers for patients presenting to a physician for surgery to remove a mass in their pelvis and to continue to evaluate these types of patients using the ROMA algorithm for post-market benefits.</brief_summary>
	<brief_title>New Biomarkers Evaluating Ovarian Cancer</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Female, age 18 years or older Adnexal mass present documented by imaging Scheduled to undergo surgery based on a finding of adnexal mass Able and willing to provide Informed Consent Previous history of ovarian cancer Previous history of bilateral oophorectomy Currently known to be pregnant Unable to provide informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Adnexal Mass</keyword>
	<keyword>Pelvic Mass</keyword>
</DOC>